Back to overview

Pregnancy and breastfeeding in inflammatory bowel disease.

Type of publication Peer-reviewed
Publikationsform Review article (peer-reviewed)
Publication date 2012
Author Biedermann Luc, Rogler Gerhard, Vavricka Stephan R, Seibold Frank, Seirafi Mariam,
Project The role of SLC transporters in autophagy and inflammatory bowel disease
Show all

Review article (peer-reviewed)

Journal Digestion
Volume (Issue) 86 Suppl 1
Page(s) 45 - 54
Title of proceedings Digestion
DOI 10.1159/000341941


Inflammatory bowel disease (IBD) is frequent in women during their peak reproductive years. Accordingly, a significant number of questions and uncertainties arise from this population regarding the risk of transmission of IBD to the offspring, the impact of the disease and therapies on the fertility, the role of the disease on the course of the pregnancy and the mode of delivery, the impact of the therapy on the pregnancy and fetal development as well as breastfeeding. The safety of medical therapy during pregnancy and lactation is a major concern for both pregnant women and their partners as well as for physicians. As a general rule, it can be stated that the benefit of continuing medical therapy in IBD during pregnancy outweighs the potential risks in the vast majority of instances. This article will review recent developments on this topic consistent with the European Crohn's and Colitis Organization guidelines.